VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2014

Aug 28, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2014-08-27

Reporting Person: BOGER JOSHUA S (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-08-27	Common Stock	M	5200	$11.27	Acquired	344095	Direct
2014-08-27	Common Stock	S	4700	$93.25	Disposed	339395	Direct
2014-08-27	Common Stock	S	500	$93.91	Disposed	338895	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-08-27	Stock Option (right to buy)	$11.27	M	5200	Disposed	2014-10-06	Common Stock (5200)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	300000	Indirect
Common Stock	13286	Indirect

Footnotes

F1: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2: Open market sales reported on this line occurred at a weighted average price of $93.25 (range $92.77 to $93.75).

F3: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4: Open market sales reported on this line occurred at a weighted average price of $93.91 (range $93.78 to $94.07).

F5: Common stock held in grantor retained annuity trusts.

F6: Fully vested.